These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11715819)

  • 1. Oral prodrug enters cephalosporin market.
    Thompson CA
    Am J Health Syst Pharm; 2001 Nov; 58(21):2018. PubMed ID: 11715819
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical evaluation of S-1108 in the treatment of pediatric infections].
    Furukawa S; Okada T
    Jpn J Antibiot; 1993 Dec; 46(12):1088-95. PubMed ID: 8107272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of a new cephem S-1108 in infants and children].
    Kino M; Hihashino H; Kobayashi Y
    Jpn J Antibiot; 1993 Dec; 46(12):1075-82. PubMed ID: 8107270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
    Schatz BS; Karavokiros KT; Taeubel MA; Itokazu GS
    Ann Pharmacother; 1996 Mar; 30(3):258-68. PubMed ID: 8833562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic approval.
    Nurse Pract; 2002 Feb; 27(2):57. PubMed ID: 11858589
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.
    Beresford E; Biek D; Jandourek A; Mawal Y; Riccobene T; Friedland HD
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):123-35. PubMed ID: 24494793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic and clinical studies of cefdinir in pediatric field].
    Fukushima N; Wagatsuma Y; Takase A; Ishikawa A; Takahashi S
    Jpn J Antibiot; 1990 Oct; 43(10):1783-8. PubMed ID: 2086815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftaroline fosamil: a new broad-spectrum cephalosporin.
    Laudano JB
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii11-8. PubMed ID: 21482565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of oral cephalosporins, KR-984055 and its prodrugs, KR-999001 and KR-999002, in the rat.
    Park YS; Woo SK; Jung MH; Kwon KI
    Arch Pharm Res; 2003 Jan; 26(1):83-8. PubMed ID: 12568364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefditoren (Spectracef)--a new cephalosporin.
    Med Lett Drugs Ther; 2002 Jan; 44(1122):5-6. PubMed ID: 11856949
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with S-1108 on bacterial infection in the pediatric field].
    Takeda E; Ito M; Kuroda Y
    Jpn J Antibiot; 1993 Dec; 46(12):1096-101. PubMed ID: 8107273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
    Magni L; Lionell C
    Scand J Infect Dis Suppl; 1990; 74():185-9. PubMed ID: 2097707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin.
    Klein JO
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S183. PubMed ID: 1617035
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential therapy with intravenous and oral cephalosporins.
    Janknegt R; van der Meer JW
    J Antimicrob Chemother; 1994 Jan; 33(1):169-77. PubMed ID: 8157558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of the cephalosporin antibiotic Zinnat under polyclinic conditions in treating patients with bronchopulmonary infections].
    Bart BIa; Solov'ev SS; Zaseeva OV; Benevskaia VF; Mikhaĭlusova MP; Romanova MV; Kasatikova LA
    Ter Arkh; 1996; 68(12):36-9. PubMed ID: 9054035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftaroline: a comprehensive update.
    Kaushik D; Rathi S; Jain A
    Int J Antimicrob Agents; 2011 May; 37(5):389-95. PubMed ID: 21420284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of cefprozil in the treatment of various infectious diseases in children].
    Wakiguchi H; Ohishi N; Kido S; Takechi T; Takeda K; Yoshimura K; Nomura I; Fujieda M; Araki K; Kurashige T
    Jpn J Antibiot; 1992 Dec; 45(12):1676-83. PubMed ID: 1289587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delafloxacin: First Global Approval.
    Markham A
    Drugs; 2017 Sep; 77(13):1481-1486. PubMed ID: 28748399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.